Darren L. Asquith
- Immunology top 1%
- IL-33, ST2, and ILC Pathways 5
- Psoriasis: Treatment and Pathogenesis 5
- Immune Cell Function and Interaction 3
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies 4
- Spondyloarthritis Studies and Treatments 3
- Systemic Lupus Erythematosus Research 3
- Cancer Research top 5%
- Immunology and Allergy top 5%
- Hematology top 5%
-
- Eosinophilic Esophagitis 3
- Cholesterol and Lipid Metabolism 3
- Co-authors
- Iain B. McInnesAshley M. MillerFoo Y. LiewAxel J. HueberNaveed SattarDamo XuAndrew H. BakerLaura Denby
- Journals
- Proceedings of the National Academy of Sciences (1 paper)The Journal of Experimental Medicine (2 papers)Blood (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Darren L. Asquith
23 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Immunology 1.5k
- Rheumatology 499
- Cancer Research 372
- Immunology and Allergy 91
- Hematology 166
Countries citing papers authored by Darren L. Asquith
This map shows the geographic impact of Darren L. Asquith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren L. Asquith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren L. Asquith more than expected).
Fields of papers citing papers by Darren L. Asquith
This network shows the impact of papers produced by Darren L. Asquith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren L. Asquith. The network helps show where Darren L. Asquith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Darren L. Asquith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Long-Term Treatment with Secukinumab on Cardio-Metabolic Profile in Patients with Active Ankylosing Spondylitis and Psoriatic Arthritis: Pooled 3 Year Analysis | 2019 | 1 |
| 2 | 2019 | 13 | |
| 3 | 2018 | 1 | |
| 4 | 2016 | 55 | |
| 5 | 2016 | 55 | |
| 6 | 2015 | 31 | |
| 7 | 2013 | 36 | |
| 8 | 2012 | 56 | |
| 9 | 2012 | 28 | |
| 10 | MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisbreakdown → | 2011 | 503 |
| 11 | 2011 | 21 | |
| 12 | 2011 | 137 | |
| 13 | 2010 | 304 | |
| 14 | 2010 | 14 | |
| 15 | 2010 | 20 | |
| 16 | 2010 | 276 | |
| 17 | 2009 | 42 | |
| 18 | 2009 | 272 | |
| 19 | IL-33 reduces the development of atherosclerosisbreakdown → | 2008 | 543 |
| 20 | 2007 | 69 |
About Darren L. Asquith
Darren L. Asquith is a scholar working on Immunology, Rheumatology and Immunology and Allergy, having authored 23 papers that have together received 2.6k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Eosinophilic Esophagitis (3 papers), Spondyloarthritis Studies and Treatments (3 papers), Immune Cell Function and Interaction (3 papers), Cholesterol and Lipid Metabolism (3 papers) and Systemic Lupus Erythematosus Research (3 papers). The work is most often cited by research in Immunology (1.5k citations), Rheumatology (499 citations) and Cancer Research (372 citations). Darren L. Asquith has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Iain B. McInnes, Ashley M. Miller, Foo Y. Liew, Axel J. Hueber, Naveed Sattar, Damo Xu, Andrew H. Baker, Laura Denby, Yubin Li and James H. Reilly. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.